These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2887224)
21. HTLV-III infection in homosexuals and hemophiliacs in Sweden. Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
23. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592 [TBL] [Abstract][Full Text] [Related]
24. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States. Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787 [TBL] [Abstract][Full Text] [Related]
25. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia. Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of AIDS-associated oral lesions in a cohort of patients with hemophilia. Bolski E; Hunt RJ Oral Surg Oral Med Oral Pathol; 1988 Apr; 65(4):406-10. PubMed ID: 3163132 [TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs. Ragni MV; O'Brien TA; Reed D; Spero JA; Lewis JH AIDS Res Hum Retroviruses; 1988 Jun; 4(3):223-31. PubMed ID: 3165003 [TBL] [Abstract][Full Text] [Related]
28. [The HIV problem of factor VIII-substituted hemophiliacs from the diagnostic and prognostic viewpoints]. Wernet P; Göhring S; Sugg U; Brackmann HH; Kessler M; Egli H; Schneider W Beitr Infusionther Klin Ernahr; 1987; 18():21-4. PubMed ID: 3125827 [No Abstract] [Full Text] [Related]
29. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Eyster ME; Gail MH; Ballard JO; Al-Mondhiry H; Goedert JJ Ann Intern Med; 1987 Jul; 107(1):1-6. PubMed ID: 3496028 [TBL] [Abstract][Full Text] [Related]
30. Delayed seroconversion to HIV in a hemophiliac. von Hintzenstern J; Jahn G; Mang K; Harms D; Fleckenstein B Klin Wochenschr; 1988 May; 66(9):410-1. PubMed ID: 3164792 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus-1 disease progression in hemophiliacs. Becherer PR; Smiley ML; Matthews TJ; Weinhold KJ; McMillan CW; White GC Am J Hematol; 1990 Jul; 34(3):204-9. PubMed ID: 2163586 [TBL] [Abstract][Full Text] [Related]
32. AIDS and immunologic abnormalities in European and American hemophiliacs. Green D Scand J Haematol Suppl; 1984; 40():367-9. PubMed ID: 6433463 [No Abstract] [Full Text] [Related]
33. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France. Mathez D; Leibovitch J; Sultan Y; Maisonneuve P N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879 [No Abstract] [Full Text] [Related]
34. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. Andrews CA; Sullivan JL; Brettler DB; Brewster FE; Forsberg AD; Scesney S; Levine PH J Pediatr; 1987 Nov; 111(5):672-7. PubMed ID: 2959763 [TBL] [Abstract][Full Text] [Related]
35. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates. Goldsmith JM; Deutsche J; Tang M; Green D Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091 [TBL] [Abstract][Full Text] [Related]
36. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up. Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820 [TBL] [Abstract][Full Text] [Related]
37. HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors. Evensen SA; Ulstrup J; Skaug K; Frøland SS; Glomstein A; Rollag H Eur J Haematol; 1987 Jul; 39(1):44-8. PubMed ID: 3115823 [TBL] [Abstract][Full Text] [Related]
38. Age and human immunodeficiency virus infection in persons with hemophilia in California. Holman RC; Gomperts ED; Jason JM; Abildgaard CF; Zelasky MT; Evatt BL Am J Public Health; 1990 Aug; 80(8):967-9. PubMed ID: 2114801 [TBL] [Abstract][Full Text] [Related]
39. Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia. Shannon BT; Roach J; Cheek-Luten M; Orosz C; Ruymann FB J Clin Immunol; 1986 Mar; 6(2):121-9. PubMed ID: 3086364 [TBL] [Abstract][Full Text] [Related]
40. Development and early natural history of HTLV-III antibodies in persons with hemophilia. Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]